Vaccine

According to research, almost $2 billion has been lost on unused COVID-19 vaccinations during the course of the pandemic. Pfizer, Moderna, Johnson & Johnson, and Novavax are four vaccine brands that have had more than 300 million…

The CDC's new study confirms JYNNEOS' two-dose vaccine is highly effective against Mpox during a potential summer outbreak. The study revealed that a single dose of the JYNNEOS vaccine had a 75% effectiveness rate, while a two-dose…

Russia extended an offer of assistance and collaboration to other nations in an effort to combat and prevent the next COVID-19 pandemic. The Russian Ministry of Foreign Affairs criticized the World Health Organization in a statement…

The U.S. Food and Drug Administration has authorized the respiratory syncytial virus (RSV) vaccine manufactured by GSK Plc. It is the first shot to be approved for protection against a common respiratory disease that can be fatal in the…

For people who only received their primary series of COVID-19 vaccine, Omicron infection effectiveness dropped dramatically after six months. The study may not accurately reflect the effectiveness of vaccines in the United States due to…

COVID-19 immunity is temporary after vaccination or infection. Researchers examined long shot protection studies in a May 3 JAMA Network Open study. The Italian-led researchers examined 40 studies on COVID-19 vaccination status and…

The development of vaccinations against cancer, cardiovascular, autoimmune, and other diseases may be completed by 2030, according to a pharmaceutical company. Chief medical officer of pharmaceutical firm Moderna, Dr. Paul Burton, claims…

According to preliminary findings from two company-funded trials, a Pfizer respiratory syncytial virus (RSV) vaccine protected newborns and older adults from sickness caused by this virus. The vaccination was administered during…